Dachaigh › Leukemia biphenotypic geur › New Hampshire

Sgrùdaidhean clionaigeach Leukemia biphenotypic geur ann an New Hampshire

Tha 3 sgrùdaidhean airson Leukemia biphenotypic geur a’ lorg phàirtichean aig làraichean ann an New Hampshire.

Teacsa sgrùdaidh oifigeil (Beurla)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon

A’ fastadhÌre 2

365 Days · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon

A’ fastadhÌre 3

365 Days – 25 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon

A’ fastadhÌre 1/2

Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.